154 related articles for article (PubMed ID: 11735811)
21. [Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue].
Zhao H; Zeng ZY; Chen FJ; Xu GP; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2003 Feb; 22(2):206-9. PubMed ID: 12600302
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system.
Squarize CH; Castilho RM; Santos Pinto D
J Oral Pathol Med; 2002 Aug; 31(7):379-84. PubMed ID: 12224530
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
Shao X; Tandon R; Samara G; Kanki H; Yano H; Close LG; Parsons R; Sato T
Int J Cancer; 1998 Aug; 77(5):684-8. PubMed ID: 9688299
[TBL] [Abstract][Full Text] [Related]
25. PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.
Kanamori Y; Kigawa J; Itamochi H; Sultana H; Suzuki M; Ohwada M; Kamura T; Sugiyama T; Kikuchi Y; Kita T; Fujiwara K; Terakawa N
Int J Cancer; 2002 Aug; 100(6):686-9. PubMed ID: 12209607
[TBL] [Abstract][Full Text] [Related]
26. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.
Depowski PL; Rosenthal SI; Ross JS
Mod Pathol; 2001 Jul; 14(7):672-6. PubMed ID: 11454999
[TBL] [Abstract][Full Text] [Related]
27. PTEN/MMAC1 expression in esophageal squamous cell carcinomas.
Ding Y; Shimada Y; Kano M; Itami A; Kawabe A; Maeda M; Li Z; Hong T; Sato F; Kaganoi J; Imamura M
Int J Oncol; 2000 Oct; 17(4):695-9. PubMed ID: 10995879
[TBL] [Abstract][Full Text] [Related]
28. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
[TBL] [Abstract][Full Text] [Related]
29. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
[TBL] [Abstract][Full Text] [Related]
31. PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2004 May; 11(5):1011-5. PubMed ID: 15069540
[TBL] [Abstract][Full Text] [Related]
32. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma.
Mineta H; Miura K; Suzuki I; Takebayashi S; Amano H; Araki K; Harada H; Ichimura K; Wennerberg JP; Dictor MR
Cancer; 1999 Mar; 85(5):1011-7. PubMed ID: 10091782
[TBL] [Abstract][Full Text] [Related]
33. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
34. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
[TBL] [Abstract][Full Text] [Related]
35. [Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer].
Zhang L; Liu T; Liu H; Gao J; Gu C
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):85-8. PubMed ID: 11866895
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic and genetic alternation of PTEN in cervical neoplasm.
Cheung TH; Lo KW; Yim SF; Chan LK; Heung MS; Chan CS; Cheung AY; Chung TK; Wong YF
Gynecol Oncol; 2004 Jun; 93(3):621-7. PubMed ID: 15196854
[TBL] [Abstract][Full Text] [Related]
37. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
Lin H; Bondy ML; Langford LA; Hess KR; Delclos GL; Wu X; Chan W; Pershouse MA; Yung WK; Steck PA
Clin Cancer Res; 1998 Oct; 4(10):2447-54. PubMed ID: 9796977
[TBL] [Abstract][Full Text] [Related]
38. [Mutation and expression of tumor suppressor gene phosphatase and tensin homolog deleted in chromosome 10 in oral squamous cell carcinoma].
Li Q; Zhao JZ; Chen YN; Zhang T; Zhou L; Jin Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Nov; 44(11):660-3. PubMed ID: 20079266
[TBL] [Abstract][Full Text] [Related]
39. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma.
Koksal IT; Dirice E; Yasar D; Sanlioglu AD; Ciftcioglu A; Gulkesen KH; Ozes NO; Baykara M; Luleci G; Sanlioglu S
Urol Oncol; 2004; 22(4):307-12. PubMed ID: 15283888
[TBL] [Abstract][Full Text] [Related]
40. Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas.
Henderson YC; Wang E; Clayman GL
Laryngoscope; 1998 Oct; 108(10):1553-6. PubMed ID: 9778300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
